Timeliness in chronic kidney disease and albuminuria identification: A retrospective cohort study

BMC Family Practice

Volumn 16, Issue 1, 2015, Pages

  Fraser, Simon D S ^a   Parkes, Julie ^a   Culliford, David ^a   Santer, Miriam ^b   Roderick, Paul J ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b Aldermoor Health Centre   (United Kingdom)

Author keywords

Albuminuria; Chronic kidney disease; General practice; Risk

Indexed keywords

AGED; ALBUMINURIA; CLINICAL PRACTICE; DISEASE MANAGEMENT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; REGISTER; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALBUMINURIA; DISEASE MANAGEMENT; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84924263360     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/s12875-015-0235-8     Document Type: Article

References (45)

1. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073-81.
2. Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ. 2013;346:324.
3. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80(1):93-104.
4. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals - The Framingham heart study. Circulation. 2005;112(7):969-75.
5. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421-6.
6. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals - The HUNT II study. Arch Intern Med. 2007;167 (22):2490-6.
7. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010;303(5):423-9.
8. Warnock DG, Muntner P, McCullough PA, Zhang X, McClure LA, Zakai N, et al. Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis. 2010;56(5):861-71.
9. Kerr M, Bray B, Medcalf J, O'Donoghue DJ, Matthews B. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012;27 Suppl 3:73-80.
10. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am SocNephrol. 2005;16(11):3365-70.
11. Blakeman T, Harding S, O'Donoghue D. Acute kidney injury in the community: why primary care has an important role. Br J Gen Pract. 2013;63:173-4.
12. National Institute for Health and Clinical Excellence guideline 73. Chronic Kidney disease. Early identification and management of chronic kidney disease in adults in primary and secondary care. 2008.
13. Kidney Disease: Improving Global Outcomes(KDIGO). 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney IntSuppl. 2013;3(1):150.
14. The National Kidney Foundation Kidney Disease Outcomes Quality Initiative. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):1-266.
15. The National Service Framework for Renal Services. Part Two: Chronic Kidney Disease, Acute Renal Failure and End of Life Care. Department of Health; London, 2005. Available at: http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod-consum-dh/groups/dh-digitalassets/@dh/@en/documents/digitalasset/dh-4102680.pdf. Last accessed March 16th 2014.
16. Quality and Outcomes Framework guidance for GMS contract 2011/12. Delivering investment in general practice. NHS Employers and British Medical Association; London, 2011.Available at: http://www.nhsemployers.org//media/Employers/Documents/Primary%20care%20contracts/QOF/2011-12/Quality%20and%20Outcomes%20Framework%20guidance%20for%20GMS%20contract%202011-12%20-%20Delivering%20investment%20in%20general%20practice.pdf. Last accessed March 16th 2014.
17. NHS Health Check Programme Best Practice Guidance. Department of Health; London, 2013. Available at: http://www.healthcheck.nhs.uk/commissioners-and-healthcare-professionals/national-guidance/. Last accessed March 16th 2014.
18. McIntyre NJ, Fluck R, McIntyre C, Taal M. Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease. Br J Gen Pract. 2012;62(597):227-32.
19. Addressing low chronic kidney disease prevalence in primary care. NHS Kidney Care 2013. Available at: http://www.cmkcn.nhs.uk/attachments/article/37/Addressing%20Low%20Chronic%20Kidney%20Disease%20Prevalence%20in%20Primary%20Care[1].pdf. Last accessed 2nd February 2015.
20. Quality and Outcomes Framework GP Practice Results: Health and Social Care Information Centre; 2013. Available at: http://qof.hscic.gov.uk. Last accessed 6th January 2015.
21. Lusignan SD, Gallagher H, Jones S, Chan T, van Vlymen J, Tahir A, et al. Audit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results. Kidney Int. 2013;84(3):609-20.
22. Fraser SD, Roderick PJ, Aitken G, Roth M, Mindell JS, Moon G, et al.: Chronic kidney disease, albuminuria and socioeconomic status in the Health Surveys for England 2009 and 2010. J Public Health (Oxf) 2012, Nov 25. [Epub ahead of print].
23. Jain P, Calvert M, Cockwell P, McManus RJ. The need for improved identification and accurate classification of stages 3-5 chronic kidney disease in primary care: retrospective cohort study. PLoS One. 2014;9:e100831.
24. Moynihan R, Glassock R, Doust J. Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased. BMJ. 2013;347:f4298.
25. Blakeman T, Protheroe J, Chew-Graham C, Rogers A, Kennedy A. Understanding the management of early-stage chronic kidney disease in primary care: a qualitative study. Br J GenPract. 2012;62:233-42.
26. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39(5):920-9.
27. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247-54.
28. Siekmann L. Determination of creatinine in human serum by isotope dilution-mass spectrometry definitive methods in clinical chemistry, IV. J ClinChemClinBiochem. 1985;23(3):137-44.
29. Jordan H, Roderick P, Martin D. The index of multiple deprivation 2000 and accessibility effects on health. J Epidemiol Community Health. 2004;58(3):250-7.
30. NHS UK Read Codes Version 2: Health and Social Care Information Centre, 2013. Available at: http://systems.hscic.gov.uk/data/uktc/readcodes. Last accessed 6th January 2015.
31. de Lusignan S, van Weel C. The use of routinely collected computer data for research in primary care: opportunities and challenges. FamPract. 2006;23(2):253-63.
32. Stevens PE, O'Donoghue DJ, de Lusignan S, Van Vlymen J, Klebe B, Middleton R, et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 2007;72(1):92-9.
33. Stevens PE, de Lusignan S, Farmer CK, Tomson CR. Engaging primary care in CKD initiatives: the UK experience. Nephrol Dial Transplant. 2012;27 Suppl 3:5-11.
34. Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am SocNephrol. 2005;16:529-38.
35. Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, et al. Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care. BMC FamPract. 2013;14:88. doi:10.1186/1471-2296-14-88.
36. National Institute for Health and Clinical Excellence clinical guideline 66. Type 2 diabetes. 2008.
37. McGovern AP, Rusholme B, Jones S, van Vlymen JN, Liyanage H, Gallagher H, et al. Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort study. BMC Nephrol. 2013;14:198. doi:10.1186/1471-2369-14-198.
38. IMPAKT™ Available at: http://www.impakt.org.uk/. Last accessed 28th March 2014.
39. Tangri N, Kitsios GD, Inker LA, Griffith J, Naimark DM, Walker S, et al. Risk prediction models for patients with chronic kidney disease: a systematic review. Ann Intern Med. 2013;158(8):596-603.
40. Di Angelantonio, E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ. 2010;341:4986.
41. Hippisley-Cox J, Coupland C, Robson J, Brindle P. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database. BMJ. 2010;341:c6624.
42. Blood Pressure Lowering Treatment Trialists' Collaboration, Ninomiya T, Perkovic V, Turnbull F, Neal B, Barzi F, et al. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ. 2013;347:f5680.
43. Remuzzi G, Perico N, Macia M, Ruggenenti P. The role of renin-angiotensinaldosterone system in the progression of chronic kidney disease. Kidney Int Suppl. 2005;68(99):57-65.
44. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease(Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377:2181-92.
45. Bedford M, Stevens PE, Wheeler TW, Farmer CK. What is the real impact of acute kidney injury? BMC Nephrol. 2014;15:95. doi: 10.1186/1471-2369-15-95.